These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 14991869

  • 1. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A, Kyprianou N.
    Prostate; 2004 Apr 01; 59(1):91-100. PubMed ID: 14991869
    [Abstract] [Full Text] [Related]

  • 2. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K, Kyprianou N.
    J Urol; 2003 Mar 01; 169(3):1150-6. PubMed ID: 12576871
    [Abstract] [Full Text] [Related]

  • 3. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N.
    J Urol; 2003 Apr 01; 169(4):1520-5. PubMed ID: 12629407
    [Abstract] [Full Text] [Related]

  • 4. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Benning CM, Kyprianou N.
    Cancer Res; 2002 Jan 15; 62(2):597-602. PubMed ID: 11809715
    [Abstract] [Full Text] [Related]

  • 5. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N, Benning CM.
    Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806
    [Abstract] [Full Text] [Related]

  • 6. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC, Rhee J, Kyprianou N.
    Anticancer Res; 2002 Aug 15; 22(3):1673-9. PubMed ID: 12168853
    [Abstract] [Full Text] [Related]

  • 7. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK, Borkowski A, Partin AW, Isaacs JT, Jacobs SC, Kyprianou N.
    J Urol; 1999 Jun 15; 161(6):2002-8. PubMed ID: 10332490
    [Abstract] [Full Text] [Related]

  • 8. Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component.
    Anglin IE, Glassman DT, Kyprianou N.
    Prostate Cancer Prostatic Dis; 2002 Jun 15; 5(2):88-95. PubMed ID: 12496995
    [Abstract] [Full Text] [Related]

  • 9. Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.
    Keledjian K, Borkowski A, Kim G, Isaacs JT, Jacobs SC, Kyprianou N.
    Prostate; 2001 Jul 01; 48(2):71-8. PubMed ID: 11433417
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance.
    Alberti C.
    Eur Rev Med Pharmacol Sci; 2007 Jul 01; 11(1):59-64. PubMed ID: 17405349
    [Abstract] [Full Text] [Related]

  • 11. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N, Chon J, Benning CM.
    Prostate Suppl; 2000 Jul 01; 9():42-6. PubMed ID: 11056502
    [Abstract] [Full Text] [Related]

  • 12. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?
    Siddiqui EJ, Shabbir M, Thompson CS, Mumtaz FH, Mikhailidis DP.
    Anticancer Res; 2005 Jul 01; 25(6B):4281-6. PubMed ID: 16309229
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
    Kyprianou N, Jacobs SC.
    Curr Urol Rep; 2000 Aug 01; 1(2):89-96. PubMed ID: 12084321
    [Abstract] [Full Text] [Related]

  • 14. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
    Keledjian K, Garrison JB, Kyprianou N.
    J Cell Biochem; 2005 Feb 01; 94(2):374-88. PubMed ID: 15526277
    [Abstract] [Full Text] [Related]

  • 15. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Oda N, Koshimizu TA, Hayashi Y, Kiniwa M, Tsujimoto G, Kohri K.
    Prostate; 2009 Oct 01; 69(14):1521-8. PubMed ID: 19544328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of alpha-blockers in the management of prostate cancer.
    Tahmatzopoulos A, Rowland RG, Kyprianou N.
    Expert Opin Pharmacother; 2004 Jun 01; 5(6):1279-85. PubMed ID: 15163273
    [Abstract] [Full Text] [Related]

  • 18. [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
    Liu SJ, Xu KX, Wang XF, Hou SK, Wang YC.
    Zhonghua Wai Ke Za Zhi; 2004 May 22; 42(10):604-6. PubMed ID: 15265404
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.